Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-06-20 4:30 pm Sale | 2024-06-20 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 0 0.000% | -24,724,468 (Position Closed) | Filing History |
2024-01-11 4:40 pm Unchanged | 2024-01-10 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 24,724,468 39.700% | 0 (Unchanged) | Filing History |
2023-07-25 4:19 pm Purchase | 2023-07-21 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 24,724,468 39.800% | 1,735,988 (+7.55%) | Filing History |
2022-06-03 4:30 pm Purchase | 2022-06-01 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 22,988,480 40.400% | 22,988,480 (New Position) | Filing History |
2021-11-08 06:15 am Purchase | 2021-11-05 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 22,988,480 45.800% | 1,812,500 (+8.56%) | Filing |
2020-07-21 4:45 pm Unchanged | 2020-07-13 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 21,175,980 60.300% | 0 (Unchanged) | Filing |
2020-03-13 5:01 pm Purchase | 2020-02-12 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 21,175,980 60.200% | 21,175,980 (New Position) | Filing |